Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Vranckx

Showing results (281-290 of 305) with videos related to

Pageof 31
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 30, 2022
Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trialTaishi Okuno, George D Dangas, Christian Hengstenberg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 22, 2024
One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromesDavide Cao, Pascal Vranckx, Marco Valgimigli, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 16, 2025
One- versus three-month DAPT after everolimus-eluting stent implantation in diabetic patients at high bleeding risk: results from the XIENCE Short DAPT programmeAngelo Oliva, Dominick J Angiolillo, Marco Valgimigli, et al.
JAMA Cardiology|March 20, 2024
Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-AnalysisMarco Valgimigli, Felice Gragnano, Mattia Branca, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 21, 2019
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trialPly Chichareon, Yoshinobu Onuma, David van Klaveren, et al.
The New England Journal of Medicine|August 27, 2021
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding RiskMarco Valgimigli, Enrico Frigoli, Dik Heg, et al.
The New England Journal of Medicine|September 2, 2015
Bivalirudin or Unfractionated Heparin in Acute Coronary SyndromesMarco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.
JACC. Cardiovascular Interventions|October 7, 2023
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCIMarco Valgimigli, Alessandro Spirito, Samantha Sartori, et al.
American Heart Journal|February 1, 2019
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) StudyEnrico Frigoli, Pieter Smits, Pascal Vranckx, et al.
Lancet (London, England)|September 3, 2024
De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trialsMarco Valgimigli, Sung-Jin Hong, Felice Gragnano, et al.
Pageof 31

Showing results (281-290 of 305) with videos related to

Sort By:
Pageof 31
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 30, 2022
Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trialTaishi Okuno, George D Dangas, Christian Hengstenberg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 22, 2024
One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromesDavide Cao, Pascal Vranckx, Marco Valgimigli, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 16, 2025
One- versus three-month DAPT after everolimus-eluting stent implantation in diabetic patients at high bleeding risk: results from the XIENCE Short DAPT programmeAngelo Oliva, Dominick J Angiolillo, Marco Valgimigli, et al.
JAMA Cardiology|March 20, 2024
Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-AnalysisMarco Valgimigli, Felice Gragnano, Mattia Branca, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 21, 2019
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trialPly Chichareon, Yoshinobu Onuma, David van Klaveren, et al.
The New England Journal of Medicine|August 27, 2021
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding RiskMarco Valgimigli, Enrico Frigoli, Dik Heg, et al.
The New England Journal of Medicine|September 2, 2015
Bivalirudin or Unfractionated Heparin in Acute Coronary SyndromesMarco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.
JACC. Cardiovascular Interventions|October 7, 2023
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCIMarco Valgimigli, Alessandro Spirito, Samantha Sartori, et al.
American Heart Journal|February 1, 2019
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) StudyEnrico Frigoli, Pieter Smits, Pascal Vranckx, et al.
Lancet (London, England)|September 3, 2024
De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trialsMarco Valgimigli, Sung-Jin Hong, Felice Gragnano, et al.
Pageof 31